16-Jan-18, Business Korea
The Korea National Enterprise for Clinical Trials has announced that the US had the most clinical trials in the world, taking up nearly 24.5 percent of the clinical trial protocol market share in 2017.
Image: Business Korea
After the US, Germany came in second place with 5.3 percent, followed by the UK with 5 percent, Canada with 3.9 percent and China with 3.7 percent. Korea ranked sixth in the world with a 3.5 percent market share, moving two notches up from the 8th at the previous year.
In particular, Seoul topped the list with the most clinical trials per city last year. The city shows a significant gap with Houston of the US, which took second place in the world.